A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis
…, JJ Lafitte, F Lemaı̂tre, AP Meert, P Vermylen… - Lung cancer, 2000 - Elsevier
Purpose: Cisplatin (CDDP) and etoposide (VP16) are considered major standard cytotoxic
drugs for small cell lung cancer (SCLC). The present systematic review had as its objective …
drugs for small cell lung cancer (SCLC). The present systematic review had as its objective …
Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration
…, M Dewerchin, V Laudenbach, P Vermylen… - Nature …, 2001 - nature.com
Hypoxia stimulates angiogenesis through the binding of hypoxia-inducible factors to the
hypoxia-response element in the vascular endothelial growth factor (Vegf) promotor. Here, we …
hypoxia-response element in the vascular endothelial growth factor (Vegf) promotor. Here, we …
Maintenance chemotherapy for small cell lung cancer: a critical review of the literature
…, C Castaigne, S Luce, C Sotiriou, P Vermylen… - Lung cancer, 1998 - Elsevier
Maintenance chemotherapy after induction therapy is a controversial topic in small cell lung
cancer. We carried out a critical review of the literature on this topic. Since 1980, 13 …
cancer. We carried out a critical review of the literature on this topic. Since 1980, 13 …
Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma
P Vermylen, C Roufosse, A Burny… - European …, 1999 - Eur Respiratory Soc
The MaTu interval (MN)/carbonic anhydrase (CA) IX tumour-associated antigen is a protein
that is normally expressed in the gut and belongs to the carbonic anhydrase enzyme family (…
that is normally expressed in the gut and belongs to the carbonic anhydrase enzyme family (…
Detection of bronchial preneoplastic lesions and early lung cancer with fluorescence bronchoscopy: a study about its ambulatory feasibility under local anaesthesis
P Vermylen, P Pierard, C Roufosse, T Bosschaerts… - Lung cancer, 1999 - Elsevier
Background: Autofluorescence bronchoscopy (AB) enhances the bronchoscopist’s ability to
diagnose bronchial preneoplastic lesions and early cancer. We undertook a study to assess …
diagnose bronchial preneoplastic lesions and early cancer. We undertook a study to assess …
Synchronous roentgenographically occult lung carcinoma in patients with resectable primary lung cancer
P Pierard, P Vermylen, T Bosschaerts, C Roufosse… - Chest, 2000 - Elsevier
… Author links open overlay panel Philippe Pierard MD a , Philippe Vermylen MD d , Thierry
Bosschaerts MD e , Candice … The criterion for statistical significance was taken as p < 0.05 …
Bosschaerts MD e , Candice … The criterion for statistical significance was taken as p < 0.05 …
Hydraulic fracturing, microseismic magnitudes, and stress evolution in the Barnett Shale, Texas, USA
JP Vermylen, MD Zoback - SPE Hydraulic Fracturing Technology …, 2011 - onepetro.org
We present new techniques to analyze the effectiveness of hydraulic fracturing for stimulating
production in shale gas reservoirs. The case study we have analyzed involves five parallel …
production in shale gas reservoirs. The case study we have analyzed involves five parallel …
[BOOK][B] Geomechanical studies of the Barnett shale, Texas, USA
JP Vermylen - 2011 - books.google.com
This thesis presents five studies of a gas shale reservoir using diverse methodologies to
investigate geomechanical and transport properties that are important across the full reservoir …
investigate geomechanical and transport properties that are important across the full reservoir …
Phase II and III studies with new drugs for non-small cell lung cancer: a systematic review of the literature with a methodology quality assessment.
…, C Mascaux, E Rubesova, P Vermylen… - Anticancer …, 1999 - europepmc.org
We carried out a systematic review of new drugs active in non-small cell lung carcinoma (NSCLC).
Fifty five phase II and III trials were reviewed (vinorelbine (19 trials), paclitaxel (15), …
Fifty five phase II and III trials were reviewed (vinorelbine (19 trials), paclitaxel (15), …
Retinoic acid receptor and retinoid X receptor alterations in lung cancer precursor lesions
…, MP Gaube, D Le Faou, J Siat, J Borelly, P Vermylen… - Cancer research, 2000 - AACR
… (P < 0.05 and P < 0.03). RAR-β marker losses also increased from the first to the last group
studied (P < … expression and correlated p53 increased immunoreactivity (P < 0.02). Losses at …
studied (P < … expression and correlated p53 increased immunoreactivity (P < 0.02). Losses at …